Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 1
2007 5
2008 3
2009 5
2010 1
2011 6
2012 4
2013 1
2014 2
2015 1
2016 4
2017 4
2018 1
2019 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Multidisciplinary management in Merkel cell carcinoma.
Matkowski R, Lata E, Zietek M, Halon A, Forgacz J, Szynglarewicz B. Matkowski R, et al. Among authors: szynglarewicz b. J Dermatolog Treat. 2014 Oct;25(5):409-14. doi: 10.3109/09546634.2012.756969. Epub 2013 Aug 13. J Dermatolog Treat. 2014. PMID: 23216365 Review.
Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence.
Dołęga-Kozierowski B, Kasprzak P, Lis M, Szynglarewicz B, Matkowski R, Sawicki M, Dymek M, Szumiejko A, Carmo G, Kwiatkowski A, Soliński DG, Ptak M. Dołęga-Kozierowski B, et al. Among authors: szynglarewicz b. Breast Cancer Res Treat. 2023 Nov;202(1):33-43. doi: 10.1007/s10549-023-07056-1. Epub 2023 Jul 25. Breast Cancer Res Treat. 2023. PMID: 37490172 Free PMC article.
[Prognostic factors in colorectal cancer].
Grzebieniak Z, Szynglarewicz B. Grzebieniak Z, et al. Among authors: szynglarewicz b. Przegl Lek. 2004;61(1):43-53. Przegl Lek. 2004. PMID: 15230106 Review. Polish.
Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme.
Doraczynska-Kowalik A, Michalowska D, Matkowski R, Czykalko E, Blomka D, Semeniuk M, Abrahamowska M, Janus-Szymanska G, Mlynarczykowska P, Szynglarewicz B, Pawlak I, Maciejczyk A, Laczmanska I. Doraczynska-Kowalik A, et al. Among authors: szynglarewicz b. Front Genet. 2022 Sep 12;13:941375. doi: 10.3389/fgene.2022.941375. eCollection 2022. Front Genet. 2022. PMID: 36171877 Free PMC article.
Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.
Jakabova A, Bielcikova Z, Pospisilova E, Matkowski R, Szynglarewicz B, Staszek-Szewczyk U, Zemanova M, Petruzelka L, Eliasova P, Kolostova K, Bobek V. Jakabova A, et al. Among authors: szynglarewicz b. Breast Cancer Res Treat. 2017 Dec;166(3):695-700. doi: 10.1007/s10549-017-4452-9. Epub 2017 Aug 16. Breast Cancer Res Treat. 2017. PMID: 28815327 Free PMC article.
Multimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristics.
Dołęga-Kozierowski B, Lis M, Marszalska-Jacak H, Koziej M, Celer M, Bandyk M, Kasprzak P, Szynglarewicz B, Matkowski R. Dołęga-Kozierowski B, et al. Among authors: szynglarewicz b. Front Oncol. 2022 Aug 22;12:855519. doi: 10.3389/fonc.2022.855519. eCollection 2022. Front Oncol. 2022. PMID: 36072800 Free PMC article.
CD46 Expression is an unfavorable prognostic factor in breast cancer cases.
Maciejczyk A, Szelachowska J, Szynglarewicz B, Szulc R, Szulc A, Wysocka T, Jagoda E, Lage H, Surowiak P. Maciejczyk A, et al. Among authors: szynglarewicz b. Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):540-6. doi: 10.1097/PAI.0b013e31821a0be9. Appl Immunohistochem Mol Morphol. 2011. PMID: 21617523
43 results